Syneos Health and Science 37 Announce Partnership Aimed at RWE Integration Into Clinical Trial Design

In an effort to seamlessly incorporate RWE (real world evidence) into clinical trial design, Syneos Health and Science 37 announced a unique partnership aimed at the biotech and pharmaceutical industries. Each company will bring leading technology systems and solutions designed to reduce drug development costs while improving efficiency via the incorporation of RWE.

“To bring clinical trials closer to the patient and transform product development, Decentralized Solutions from Syneos Health combines deep behavioral and therapeutic insights, agile technologies, and operational excellence. Science 37’s premier technology platform makes clinical trials virtual through its flexible, on-demand network, comprised of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices, strengthening clinical, and real-world effectiveness and yielding high-quality data collection.” Read more here.

(Source: Syneos Health, 3/29/21)